Second Sight Medical Prod...

NASDAQ: EYES · Real-Time Price · USD
4.14
-0.22 (-5.05%)
At close: Aug 31, 2022, 6:00 AM

Second Sight Medical Products Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
-130K
Cost of Revenue
n/a
Gross Profit
-130K
Operating Income
-8.91M
Interest Income
12K
Pretax Income
-8.92M
Net Income
-8.93M
Selling & General & Admin
6.32M
Research & Development
2.37M
Other Expenses
378K
Operating Expenses
9.06M
Interest Expense
12K
Selling & Marketing Expenses
n/a
Cost & Expenses
8.93M
Income Tax Expense
12K
Shares Outstanding (Basic)
10.94M
Shares Outstanding (Diluted)
10.94M
EPS (Basic)
-0.82
EPS (Diluted)
-0.82
EBITDA
-8.84M
EBIT
-8.88M
Depreciation & Amortization
70K